ASCO 2025: Lung Cancer Immunotherapy Breakthroughs from the Immuno-Oncology Symposium Lung Cancer Treatment 4 Mins Read Introduction to ASCO 2025 Lung Cancer Immunotherapy Updates At the MOASC/ANCO Immuno-Oncology Symposium held on September 6, 2025, in Marina…
Tarlatamab Phase 3 Results: New SCLC Standard at ASCO 2025 ASCO 3 Mins Read Tarlatamab Phase 3 Results SCLC ASCO 2025 The tarlatamab phase 3 results for SCLC, shared at ASCO 2025, showed a…
